Oncgnostics is a leading Germany biotech company that specializes in the development of in vitro diagnostic tests for all areas of cancer diagnosis.[...]
Oncgnostics is a leading Germany biotech company that specializes in the development of in vitro diagnostic tests for all areas of cancer diagnosis.[...]
BioPortUSA is pleased to announce the addition of two more subject matter experts to our team. Medical Device Academy is considered to be one of the top boutique FDA consultancies that also has a firm understanding of regulatory requirements from other countries around the world including CE and MDR marking. Mark Lesselroth, CEO of BioPortUSA said that “we are thrilled to have Rob Pakcard and his team on board not only because they can assist our international med-tech companies with 510K and De Novo applications but also because they have the ability to help our U.S. based clients with navigating the regulatory pathway in other parts of the world.”[...]
BioPortUSA was recently certified as the first American Life Science Consultancy for the German State of Thuringia. “This is an amazing and humbling honor” stated Mark Lesselroth, CEO of BioPortUSA. With this certification companies wishing to work with BioPort can receive refunds from the RKW Thüringia up to 40% of the total project cost. [...]
Nexterus (https://www.nexterus.com) is a leading, full-service supply chain logistics provider with a rich history of helping small to medium sized companies stay ahead of the competition by employing best in class supply chain strategies. Founded in 1948, the company is entering the 4th generation of leadership.[...]
Mark Lesselroth, CEO of BioPortUSA was recently interviewed by the German Trade Publication medizin & technik on market entry into Canada.[...]
On Thursday, September 26th, BioPortUSA organized its first summit of subject matter experts. We had participants come from as far away as Louisville, KY, Baltimore, MD and Vermont. The main goal was to bring all of our team members together to introduce them to one another, and to examine how we as a collective ecosystem could help ease the market entry process for international life science companies into the United States.[...]
Fust Charles Chambers LLP, a leading accounting firm in Upstate New York,has joined the team at BioPortUSA to better service the needs of international life science companies looking to enter or expand their presence in the USA. [...]
The U.S. Consulate in Düsseldorf, Germany will play host to a VIP Event involving BioPortUSA and EY Life Sciences on November 17th. The presentation titled “Demystifing US Market Entry” will focus on what the international medical device community needs to take into consideration when contemplating market entry into the US healthcare market. The event is slated to take place one day before the start of MEDICA (https://www.medica-tradefair.com/), the worlds largest medical device show[...]
Social Media